The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...

More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Moderna is being audited by the PMCPA after yet again being found to have brought discredit on the pharma industry, putting ...

Patient enrollment and randomization for the trial was initiated in early 2025 and is expected to be completed in 2026. In ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Moderna reiterated its full-year 2025 product sales forecast of $1.5 billion to $2.5 billion, with most expected in the ...

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% ...

Momentum is building to scale back the current recommendation that all children over 6 months old get immunized against the ...